. This dynein or dynactin blocked LPA-and Cdc42-area represents about one-third of the cell, so the MTOC stimulated MTOC reorientation. LPA also will be "reoriented" by chance in about 33% of the cells.
; data not shown). These results show that Cdc42, but not Rho or Rac, is sufficient to induce MTOC material).
reorientation. We next tested whether Rho family GTPases were involved in MTOC reorientation. LPA-induced MTOC re-MTOC reorientation occurs independent of changes in actin orientation was blocked by microinjecting dominant-negCdc42 activates the actin cytoskeleton in serum-starved ative N17Cdc42 or PAK-CRIB, a Cdc42/Rac-specific Swiss 3T3 cells by inducing filopodia [13] . In seruminhibitor [12] , but not by microinjecting dominant-negastarved NIH 3T3 cells microinjected with L61Cdc42, we tive N17Rac or botulinin C3 toxin to inhibit Rho (Figure did not detect filopodia or other significant differences in 1d,e and Supplementary material). C3 toxin blocked LPAactin distribution as revealed by phalloidin staining ( [14] . LPA-stimulated MTOC reorientation was also unaffected by CD (data not shown). These plementary material). This suggests that Golgi disruption by dynein reagents is less sensitive than MTOC reorientaresults are consistent with studies on the effect of CD on MTOC reorientation in endothelial cells and macrotion and is not responsible for the inhibition of MTOC reorientation. phages [15, 16] and suggest that stimulation of the actin cytoskeleton is not involved in Cdc42-induced MTOC reorientation. This does not completely preclude a re-MTOC reorientation and MT stabilization are regulated independently quirement for actin, since CD treatment is unlikely to
In fibroblasts, there is evidence for crosstalk between Rho affect all actin filaments [17] .
family GTPases [13] . Also, MT stabilization and MTOC reorientation occur with similar time courses after wound-
Inhibition of dynein or dynactin blocks MTOC reorientation
ing [3] , and it is not known whether MTOC reorientation The mechanism of MTOC reorientation during cell midepends on MT stabilization or vice versa. We addressed gration has not been explored; however, the repositioning these issues by first examining whether factors that altered suggests that a motor may be involved. Cytoplasmic dynein MTOC reorientation affected the formation of stable and its accessory protein, dynactin, have been implicated MTs. Stabilized MTs were detected with an antibody to in spindle positioning during cell division in a number of detyrosinated tubulin (termed Glu tubulin after the Glu systems [18] [19] [20] [21] [22] , but their role in MTOC reorientation in residue exposed by detyrosination [26]), which is a reliable migrating cells has not been studied.
marker of stabilized MTs [3, [5] [6] [7] . Inhibition of MTOC reorientation by overexpressing GFP-dynamitin ( Figure  4a shown), an alternative assay for MT stability [3, [5] [6] [7] . MTOC or the close apposition of the MTOC to the nuThese results show that MTOC reorientation itself or the cleus (Figure 3 a-d) .
factors involved in MTOC reorientation (Cdc42/dynein/ dynactin) are not involved in MT stabilization. Overexpression of the dynamitin subunit of dynactin also blocks dynein function in cells [24, 25] . Overexpressed GFP-dynamitin inhibited MTOC reorientation and, like Next, we examined whether factors that affect stable Glu MT formation affected MTOC reorientation. Inhibition the injected mAb 74.1, did not interfere detectably with the focus of the MTs at the MTOC (Figures 3e,3f and of LPA-induced stable Glu MTs by C3 toxin did not inhibit MTOC reorientation (Figure 4a,c) . Conversely, MTOC reorientation in migrating cells (see Note added in proof). There are a number of possible models for how activation of MT stabilization with L63Rho, the mDia autoinhibitory domain (DAD) [6, 27] , or constitutively dynein/dynactin may mediate MTOC reorientation, but the most straightforward one is that dynein in the cell active ⌬GBDmDia2 [6] did not stimulate MTOC reorientation (Figure 4c ). These results show that MT stabilizacortex at or near the leading edge could exert a pulling force on MTs. Movement of cortically anchored dynein tion itself or the factors involved in MT stabilization (Rho/ mDia) are not involved in MTOC reorientation.
toward MT minus ends would pull MTs and the attached MTOC toward the leading edge. With such a model, dynein activity would have to be regulated locally, and
An LPA/Cdc42 signaling pathway regulates MTOC reorientation this could be achieved directly or indirectly by Cdc42. In this study, we have shown for the first time that there Consistent with a cortical dynein pulling model is eviis a specific signal transduction pathway involved in regudence that dynein/dynactin are localized in the cortex of lating MTOC reorientation. We identified LPA as the mammalian cells [21, 30] and that they are involved in soluble external trigger and Cdc42 as the cytoplasmic MT sliding in the yeast cortex [18, 19] . Dynactin has regulator of MTOC reorientation. We found that dynein been localized on the ends of growing MTs [31] where and dynactin are required for MTOC reorientation, alit is poised to activate dynein in the cortex. though more work is needed to determine whether these components are regulated directly by Cdc42.
Our study clearly establishes that MTOC reorientation and MT stabilization are independent processes regulated To our knowledge, the wounded fibroblast system is the by separate Rho family GTPases. This is analogous to first system in which it has been possible to activate the regulation of independent actin assemblies by sepa-MTOC reorientation by introducing intracellular factors rate Rho family GTPases. And yet, the effects of Rho (e.g., L61Cdc42). This allowed us to show for the first GTPase regulation on each cytoskeletal system are distime that active Cdc42 is sufficient to trigger MTOC tinct; for actin, Rho GTPases regulate the de novo formareorientation. Previously in unstarved fibroblasts, active tion of discrete actin assemblies, whereas for MTs, Rho V12Cdc42 was shown to have no effect on Golgi reorientaGTPases modify a single array but polarize it in distinct tion, which usually reflects MTOC reorientation, always. though N17Cdc42 partially inhibited Golgi reorientation [28] . In T cells, both active and dominant-negative Cdc42 inhibit MTOC reorientation [29] . This may reflect differDo stable MTs and reoriented MTOCs perform unique or overlapping functions? Both processes contribute to an ences in cell type or alternatively, that MTOC reorientation requires cycling Cdc42 in T cells but not in fibroincrease in the number of MTs directed to the leading edge. MTOC reorientation does so by positioning the blasts, which may use other mechanisms to maintain MTOC position once it has reoriented. MTOC so that the nucleus does not come between it and the leading edge; stable MTs, which are capped and not dynamic [32] , do so by adding additional MTs that Our study is the first to implicate dynein/dynactin in are not governed by factors that restrict the number of dynamic MTs a cell can maintain. Increased numbers of MTs directed toward the leading edge would bias vesicle transport toward the leading edge, and this has been observed in wound-edge cells [33] . Stable MTs may also increase delivery or recycling of components to the leading edge by virtue of their posttranslational detyrosination, since stable Glu MTs exhibit enhanced binding to kinesin [34] and have been shown to be the preferred path for endocytic recycling (Lin et al., submitted).
Materials and methods

Chemicals and DNA constructs
LPA, L-␣-lysophosphatidic acid (1-oleoyl), was from Avanti Polar Lipids (Alabaster, Alabama, USA). Unless noted otherwise, all other chemicals were from Sigma. mDia DNA constructs were prepared as described [27] . GFP-dynamitin was prepared in the pEGFP-N1 vector (Clontech) between the EcoR1 and BamH1 sites.
Cell culture and microinjection
NIH 3T3 cells were cultured, serum-starved, and wounded as previously described [5] [6] [7] . DNAs were microinjected into nuclei as previously described [6] . C3 toxin (1 g/ml) and GST-tagged Cdc42, Rac, and Rho proteins (1 mg/ml) (Cytoskeleton, Denver, Colorado, USA) were microinjected with human IgG (1 mg/ml) as previously described [5] . GST-PAK-CRIB (residues 56-272 of PAK1B) was prepared as previously described [12] , concentrated by vacuum dialysis against H-KCl (10 mM Hepes, 140 mM KCL [pH. 7.4]), and microinjected at 3 mg/ ml. mAb 74.1 to dynein intermediate chain [35] was purified from ascites, concentrated by vacuum dialysis against H-KCl, and microinjected at 4 mg/ml.
Indirect immunofluorescence and fluorescence microscopy
Methanol fixation and staining were performed as described previously [3, 6, 26] . DAPI was used at 1 g/ml to stain nuclei. Polyclonal antibody against pericentrin (Covance, Princeton, New Jersey, USA) was used at 1:200 dilution to stain the MTOC. Rhodamine-phalloidin (Cytoskeleton) staining of paraformaldehyde-fixed cells was as described [6] . Microscopy and imaging were performed as previously described [6] .
